Search

76 Result(s)
Sort by

Biotherapeutics Discovery

Biotherapeutics Discovery

Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
Improving Access to Healthcare

Improving Access to Healthcare

According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care.
history movie

history movie

Learn more about Boehringer Ingelheim's history of more than 130 years, from the beginning in 1885 to today. We share documents and insights from our history, our business areas and our research and development activities across the decades.
Oncology Translational Science

Oncology Translational Science

Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Research Beyond Borders

Research Beyond Borders

Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Making sustainable medicines through eco-design

Making sustainable medicines through eco-design

Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Reimagining digital healthcare worldwide

Reimagining digital healthcare worldwide

How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Regional Center Vienna

Regional Center Vienna

RCV is the regional affiliate of Boehringer Ingelheim and responsible for over 30 countries in Central and Eastern Europe and Central Asia.
Chronic Kidney Disease

Chronic Kidney Disease

Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.
Drug discovery Boehringer Ingelheim

Drug discovery Boehringer Ingelheim

Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.